Todays Trendy Tickers are:
Valeant Pharmaceuticals (NYSE:VRX) is trending following an upgrade by Bidask Club. BidaskClub upgraded Valeant Pharmaceuticals (NYSE:VRX) to a Buy in a statement released on Thursday June 29, 2017. Valeant (NYSE:VRX) traded -4.14% lower during the trading session. With the last close up 5.49% from the two hundred day average. Valeant Pharmaceuticals has recorded a 50-day average of $15.84 and a 200-day moving average of $13.40. 13,814,603 shares of the stock traded hands, down from an average trading volume of 17,941,300
Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices). It operates through two segments: Developed markets and Emerging markets.
Apple was in the news when CEO Tim Cook collected nearly $90mln of Apple stock, the most allowed under a compensation package agreement, half the shares awarded are for meeting AAPL’s company performance goals. On Monday, Cook sold $43 million worth of his stock — 268,623 shares — as part of a pre-arranged plan, according to another SEC filing.
Apple Inc (Apple) designs, manufactures and markets mobile communication and media devices, personal computers, and portable digital music players, and a variety of related software, services, peripherals, networking solutions, and third-party digital content and applications. The Company’s products and services include iPhone, iPad, Mac, iPod, Apple TV, a portfolio of consumer and professional software applications, the iOS and OS X operating systems, iCloud, and a variety of accessory, service and support offerings.
Exact Sciences Corporation (NASDAQ:EXAS) have been trending positive week beginning 28/08/2017. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock was under pressure last week amid reports that mutual fund company Lord Abbett & Co. filed a securities fraud lawsuit against Valeant, alleging that it bought VRX’s debt securities at artificially inflated prices based on misleading information provided by Valeant. The lawsuit Lord Abbett filed in federal court in New Jersey — location of Valeant’s U.S. headquarter — seeks damages of $80 billion in investor losses and under the New Jersey’s racketeer influenced and corrupt organizations (RICO) laws.
This lawsuit introduces more major uncertainty for the company, which is already plagued with numerous RICO-related legal battles related to allegations that VRX used deceptive business practices, which includes price-gouging on some of its key drugs.
Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer.
The online retailer has generated much attention recently following its acquisition of Wholefoods (NASDAQ:WFM). The company yesterday announced it would slash prices by up to 43% In mid-June, Amazon.com, Inc. (NASDAQ:AMZN) announced it would pay $13.7 billion to buy Whole Foods Market, Inc. (NASDAQ:WFM). Today, Amazon celebrated its first official day in charge of WFM.
Amazon.com, Inc. offers a range of products and services through its Websites. The Company operates through three segments: North America, International and Amazon Web Services (AWS). The North America segment consists of retail sales of consumer products (including from sellers) and subscriptions through North America-focused Websites, such as www.amazon.com, www.amazon.ca and www.amazon.com.mx.